Rámón Colomer
Impact in
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer, Lipids, and Metabolism 44
- Breast Cancer Treatment Studies 36
- Oncology 148
- HER2/EGFR in Cancer Research 63
- Cancer Treatment and Pharmacology 48
- Cancer Immunotherapy and Biomarkers 19
- Co-authors
- Javier A. MenéndezRuth LupuAlejandro Vázquez‐MartínJoan BrunetH. Cortés-FunesLuciano VellónSantiago RoperoInderjit Mehmi
- Journals
- Clinical & Translational Oncology (26 papers)Journal of Clinical Oncology (24 papers)Annals of Oncology (13 papers)Cancer (8 papers)Breast Cancer Research and Treatment (8 papers)
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Rámón Colomer
225 papers receiving 8.1k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 2.6k
- Oncology 4.1k
- Pulmonary and Respiratory Medicine 1.6k
- Radiology, Nuclear Medicine and Imaging 1.1k
- Molecular Biology 3.0k
Countries citing papers authored by Rámón Colomer
This map shows the geographic impact of Rámón Colomer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rámón Colomer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rámón Colomer more than expected).
Fields of papers citing papers by Rámón Colomer
This network shows the impact of papers produced by Rámón Colomer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rámón Colomer. The network helps show where Rámón Colomer may publish in the future.
Co-authors
The 25 scholars most cited alongside Rámón Colomer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 24 | |
| 4 | 2022 | 8 | |
| 5 | 2020 | 1 | |
| 6 | 2019 | 46 | |
| 7 | 2015 | 11 | |
| 8 | 2010 | 20 | |
| 9 | 2010 | 27 | |
| 10 | 2010 | 11 | |
| 11 | 2009 | 83 | |
| 12 | Abstract #LB-256: Enzastaurin inhibits in vivo GSK3\#946; phosphorylation in early breast cancer | 2009 | 2 |
| 13 | 2008 | 33 | |
| 14 | 2008 | 33 | |
| 15 | Fatty acid metabolism in cancer cells: Differential inhibitory effects of epigallocatechin (EGCG) and C75 | 2006 | 2 |
| 16 | 2005 | 204 | |
| 17 | 2004 | 38 | |
| 18 | 2004 | 47 | |
| 19 | 2001 | 4 | |
| 20 | 1992 | 103 |
About Rámón Colomer
Rámón Colomer is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 235 papers that have together received 8.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (63 papers), Cancer Treatment and Pharmacology (48 papers), Cancer, Lipids, and Metabolism (44 papers), Breast Cancer Treatment Studies (36 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Cancer Immunotherapy and Biomarkers (19 papers), Advanced Breast Cancer Therapies (18 papers) and Inflammatory mediators and NSAID effects (17 papers). The work is most often cited by research in Cancer Research (2.6k citations), Oncology (4.1k citations), Pulmonary and Respiratory Medicine (1.6k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Molecular Biology (3.0k citations). Rámón Colomer has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Javier A. Menéndez, Ruth Lupu, Alejandro Vázquez‐Martín, Joan Brunet, H. Cortés-Funes, Luciano Vellón, Santiago Ropero, Inderjit Mehmi, Marc E. Lippman and Teresa Puig. Their work appears in journals such as Clinical & Translational Oncology, Journal of Clinical Oncology, Annals of Oncology, Cancer and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.